PhaseV

PhaseV is a biopharma software company based in Cambridge, Massachusetts that builds AI and machine-learning solutions for clinical-trial optimization. Its platform helps pharmaceutical sponsors and CROs improve trial design, reduce enrollment and cost, shorten timelines, and increase probability of success through simulation and Bayesian adaptive design (Trial Optimizer), biomarker and patient-subgroup identification (Response Optimizer), disease-progression causal analysis (Portfolio Optimizer), site selection and operational analytics (ClinOps Optimizer), and ML-based early-derived endpoint identification. PhaseV publishes no public developer API, SDK, or documentation surface; this profile captures its identity and probed domain-security posture. Backed by Accel and Insight Partners.

PhaseV is profiled on the APIs.io network. Tagged areas include Company, Ai, Clinical Trials, Biopharma, and Machine Learning.

PhaseV’s developer surface includes engineering blog, support, and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub
11.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyAiClinical TrialsBiopharmaMachine LearningLife SciencesHealthcareDrug Development

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 11.9/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 1.3 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/phasev: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Phasev Domain Security

TLSv1.3 · HSTS · DNSSEC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support
Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: phasev
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/phasev.png
name: PhaseV
description: PhaseV is a biopharma software company based in Cambridge, Massachusetts that builds AI and machine-learning
  solutions for clinical-trial optimization. Its platform helps pharmaceutical sponsors and CROs improve trial design, reduce
  enrollment and cost, shorten timelines, and increase probability of success through simulation and Bayesian adaptive design
  (Trial Optimizer), biomarker and patient-subgroup identification (Response Optimizer), disease-progression causal analysis
  (Portfolio Optimizer), site selection and operational analytics (ClinOps Optimizer), and ML-based early-derived endpoint
  identification. PhaseV publishes no public developer API, SDK, or documentation surface; this profile captures its identity
  and probed domain-security posture. Backed by Accel and Insight Partners.
url: https://raw.githubusercontent.com/api-evangelist/phasev/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- accel
- insight-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Ai
- Clinical Trials
- Biopharma
- Machine Learning
- Life Sciences
- Healthcare
- Drug Development
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/phasev-domain-security.yml
- type: Website
  url: https://www.phasevtrials.com/
- type: Blog
  url: https://www.phasevtrials.com/insights/blog
- type: PrivacyPolicy
  url: https://www.phasevtrials.com/privacy-policy
- type: Support
  url: https://www.phasevtrials.com/contact
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1